Skip to content

Darunavir once-daily approved in Europe for treatment-experienced

Social and economic circumstances impact on HIV treatment outcomes in US, Canada, Brazil, Australia

Free online tool may help doctors make treatment decisions for HIV-positive patients with drug resistance

Breaks from HIV therapy still associated with poorer outcomes 8 years later

Accelerated ageing of the immune system linked to heart disease risk in women with HIV

Updates to US HIV treatment guidelines

Atorvastatin and rosuvastatin have most favourable impact on lipids of patients with HIV

Genetic tests could predict which patients will have problems with some anti-HIV drugs

Scale up of treatment linked to rise in loss to follow-up, but those in care continue to do well